Palisade Bio (PALI) Accumulated Expenses (2010 - 2026)

Palisade Bio (PALI) has 16 years of Accumulated Expenses data on file, last reported at $122000.0 in Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 3.39% year-over-year to $122000.0 in Q1 2026; TTM through Mar 2026 was $122000.0, a 3.39% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 79.78% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $122000.0, down from $1.3 million in the prior quarter.
• Over the last five years, Accumulated Expenses for PALI reached as high as $1.3 million in Q4 2025 and fell as low as $72000.0 in Q1 2022.
• Historically, Accumulated Expenses has averaged $417941.2 across 5 years, with a median of $309000.0 in 2023.
• Across the five-year window, Accumulated Expenses plunged 73.75% in 2022 and surged 686.84% in 2023, its largest moves.
• Year by year, Accumulated Expenses stood at $574000.0 in 2022, then soared by 44.77% to $831000.0 in 2023, then retreated by 13.12% to $722000.0 in 2024, then soared by 79.78% to $1.3 million in 2025, then slumped by 90.6% to $122000.0 in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $122000.0 in Q1 2026, $1.3 million in Q4 2025, and $621000.0 in Q3 2025.